Literature DB >> 15471846

In vivo evaluation of 111In-labeled T-lymphocyte homing in experimental colitis.

Catherine van Montfrans1, Roelof J Bennink, Kora de Bruin, Wouter de Jonge, Hein J Verberne, Fiebo J W Ten Kate, Sander J H van Deventer, Anje A Te Velde.   

Abstract

UNLABELLED: Blockade of lymphocyte recruitment to the intestinal mucosa is considered a useful therapy for inflammatory bowel disease (IBD) and anti-alpha4 antibodies have clinical benefit in patients with active Crohn's disease. The aim of this study was to evaluate a scintigraphic technique to assess lymphocyte homing to the colon in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced experimental colitis (TNBS colitis) in vivo.
METHODS: TNBS-sensitized and nonsensitized murine total lymphocytes or CD4+ lymphocytes were radiolabeled with 111In-oxinate. Cells were injected into control mice (n = 5) or mice with TNBS colitis (n = 5). Specific abdominal radioactive uptake was determined by SPECT using a dedicated pinhole system 48 h after cell transfer. Radioactive colon uptake was correlated with histology and colon weight as parameters of inflammation.
RESULTS: The radioactive colon uptake was most evident in mice with TNBS colitis that received sensitized lymphocytes (uptake ratio [mean +/- SEM], 0.51 +/- 0.03 vs. 0.22 +/- 0.04; P = 0.004). The sensitized 111In-labeled lymphocytes exacerbated colitis compared with nonsensitized lymphocytes. The colon uptake correlated well with both colon weight and histologic score (R2 = 0.836 and 0.933, respectively). The use of purified 111In labeled CD4+ lymphocytes resulted in a similar scintigraphic pattern. Administration of an anti-alpha4 antibody decreased radioactivity colon uptake of the (111)In-labeled cells compared with the control antibody in mice with TNBS colitis (uptake ratio, 0.72 +/- 0.14 to 0.33 +/- 0.03; P = 0.012).
CONCLUSION: Animal pinhole SPECT can be applied for temporal and spatial analysis of the lymphocyte homing process in experimental colitis. This technique makes possible the in vivo evaluation of therapeutic efficacy of new drugs that interfere with lymphocyte migration. Moreover, colon uptake of radioactivity can be used as a parameter of disease activity in experimental colitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471846

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity.

Authors:  Hein J Verberne; Kora de Bruin; Jan B A Habraken; G Aernout Somsen; Jos L H Eersels; Frits Moet; Jan Booij; Berthe L F van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-20       Impact factor: 9.236

2.  An Ultrahigh Resolution SPECT System for I-125 Mouse Brain Imaging Studies.

Authors:  L J Meng; G Fu; E J Roy; B Suppe; C T Chen
Journal:  Nucl Instrum Methods Phys Res A       Date:  2009-03-01       Impact factor: 1.455

3.  In vivo imaging of mucosal CD4+ T cells using single photon emission computed tomography in a murine model of colitis.

Authors:  Bittoo Kanwar; Dong Wei Gao; Andrew B Hwang; James P Grenert; Simon P Williams; Benjamin Franc; Joseph M McCune
Journal:  J Immunol Methods       Date:  2007-10-16       Impact factor: 2.303

4.  Molecular SPECT Imaging: An Overview.

Authors:  Magdy M Khalil; Jordi L Tremoleda; Tamer B Bayomy; Willy Gsell
Journal:  Int J Mol Imaging       Date:  2011-04-05

5.  SPECT-computed tomography in rats with TNBS-induced colitis: A first step toward functional imaging.

Authors:  Rachel Marion-Letellier; Pierre Bohn; Romain Modzelewski; Pierre Vera; Moutaz Aziz; Charlène Guérin; Guillaume Savoye; Céline Savoye-Collet
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

6.  Monitoring the efficacy of dendritic cell vaccination by early detection of (99m) Tc-HMPAO-labelled CD4(+) T cells.

Authors:  Ehsan Sharif-Paghaleh; John Leech; Kavitha Sunassee; Niwa Ali; Pervinder Sagoo; Robert I Lechler; Lesley A Smyth; Giovanna Lombardi; Gregory E Mullen
Journal:  Eur J Immunol       Date:  2014-04-14       Impact factor: 5.532

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.